With BioPharma, you gain unparalleled insights into drugs on the market and in development, empowering you to navigate the complex biotech and pharmaceutical sectors with ease and make data-driven decisions with confidence.
What Is BioPharma?
No more juggling between platforms. BioPharma couples drug data with detailed consensus estimates into one user-friendly drug intelligence platform.
Whether you are a pharmaceutical or biotech company or investor, leverage metadata on over 6,300+ marketed and pipeline drugs to filter and assess the competitive landscape by drug segment.
Say goodbye to data silos. BioPharma’s extensive drug data repository consolidates information from diverse sources, saving you precious time.
Customize intuitive charts to match your preferences and eliminate manual data compilation to quickly gain a snapshot into a drug or drug segment.
BioPharma elevates your understanding of market sentiment with drug-specific pages which contain tools to analyze drug sales over time, and view analyst estimates.
Revisions in drug performance happen year-round. Stay informed with alerts for changes to drug forecasts.
BioPharma offers granular consensus and broker estimates for over 6,300+ drugs, sourced directly from sell-side models.
Flexibility is key when assessing drug forecasts. BioPharma lets you view risk-adjusted or unadjusted revenues instantly, adapting to your workflow needs.
We provide the market’s view to enable you to extract valuable insights and gain an investment edge. To do that, we provide multiple ways for you to access and incorporate our data directly into your workflow.
Our web-based interface enables you to quickly screen through an extensive drug metadata repository of marketed and pipeline drugs. We offer charting tools that empower you to visualize complex data and easily explore new ideas, as well as extended forecast horizons that allow you to analyze early-stage drugs in greater detail.
The ability to ask questions about the competitive landscape and receive answers backed by data is critical when looking for differentiated opportunities. BioPharma’s homepage enables powerful screening.
The average healthcare analyst uses at least 4 different sources when mapping attributes like mechanism of action, active pharmaceutical ingredient, and pending indications for drugs. Drug pages consolidate this information.
Healthcare analysts need to understand the totality of market expectations for drugs, but traditional data providers don’t offer granularity. The Sales Analysis feature allows users to break down revenue by indication, geography, and other related metrics.
6,300+ Drugs | 1,000+ Indications | 1,200+ MOAs | 200+ Contributing Brokers
Identify new opportunities, evaluate market competitiveness, gauge market expectations, analyze historical data, access forward-looking estimates, and conduct rapid financial analysis at the drug level.
